MiR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Qingguo ^a,b   Liang, Xin ^c   Wang, Yuwei ^a,b   Meng, Xianke ^a,b   Xu, Ye ^a,b   Cai, Sanjun ^a,b   Wang, Zhimin ^d   Liu, Jianwen ^c   Cai, Guoxiang ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 PROTEIN, HUMAN; MICRORNA; MIRN139 MICRORNA, HUMAN; PROTEIN BCL 2;

3' UNTRANSLATED REGION; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; DNA MICROARRAY; DOWN REGULATION; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; HT-29 CELL LINE; HUMAN; MOUSE; SEQUENCE ANALYSIS; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE ANALYSIS, RNA;

EID: 84973382865     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27157     Document Type: Article

References (37)

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA: a cancer journal for clinicians 65, 5-29 (2015).
2. Cekaite, L., Eide, P. W., Lind, G. E., Skotheim, R. I. & Lothe, R. A. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget 7, 6476-6505 (2016).
3. Thomas, J., Ohtsuka, M., Pichler, M. & Ling, H. MicroRNAs: Clinical Relevance in Colorectal Cancer. Int J Mol Sci 16, 28063-28076 (2015).
4. He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531 (2004).
5. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
6. Hollis, M. et al. MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity. World journal of gastroenterology 21, 8284-8292 (2015).
7. Hur, K. et al. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Gut. doi: 10.1136/gutjnl-2014-308737(2015).
8. Li, T., Gao, F. & Zhang, X. P. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Oncology reports 33, 607-614 (2015).
9. Li, J., Chen, Y., Zhao, J., Kong, F. & Zhang, Y. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer letters 304, 52-59 (2011).
10. Chiang, Y. et al. Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 15, 63-70 (2011).
11. Yip, K. W. & Reed, J. C. Bcl-2 family proteins and cancer. Oncogene 27, 6398-6406 (2008).
12. Li, X. F. et al. Correlation study of Bcl-2, B7-H1, EGFR, VEGF and colorectal cancer. American journal of cancer research 5, 2277-2284 (2015).
13. Trisciuoglio, D. et al. Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. J Cell Physiol 205, 414-421 (2005).
14. An, J. et al. Constitutive expression of Bcl-2 induces epithelial-Mesenchymal transition in mammary epithelial cells. BMC cancer 15, 476 (2015).
15. Sun, T. et al. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology 54, 1690-1706 (2011).
16. Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nature reviews. Molecular cell biology 9, 47-59 (2008).
17. Reed, J. C. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34, 9-19 (1997).
18. Wang, V. & Wu, W. MicroRNA-based therapeutics for cancer. BioDrugs 23, 15-23 (2009).
19. Huang, L. et al. Neoadjuvant chemotherapy followed by surgery versus surgery alone for colorectal cancer: meta-analysis of randomized controlled trials. Medicine 93, e231 (2014).
20. Zhang, Y. et al. Involvement of aberrant miR-139/Jun feedback loop in human gastric cancer. Biochim Biophys Acta 1853, 481-488 (2015).
21. Krishnan, K. et al. miR-139-5p is a regulator of metastatic pathways in breast cancer. RNA 19, 1767-1780 (2013).
22. Sun, C. et al. Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 6, 39756-39792 (2015).
23. Qiu, G., Lin, Y., Zhang, H. & Wu, D. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Biochem Biophys Res Commun 463, 315-321 (2015).
24. Wong, C. C. et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 140, 322-331 (2011).
25. Lim, S. H. et al. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer. Journal of clinical pathology 67, 848-853 (2014).
26. Fuchs, B. C. et al. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer research 68, 2391-2399 (2008).
27. McConkey, D. J. et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 28, 335-344 (2009).
28. Huang, D. et al. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. Scientific reports 6, 20502 (2016).
29. Vega, S. et al. Snail blocks the cell cycle and confers resistance to cell death. Genes & development 18, 1131-1143 (2004).
30. Saxena, M., Stephens, M. A., Pathak, H. & Rangarajan, A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis 2, e179 (2011).
31. Zhang, L., Yu, J., Park, B. H., Kinzler, K. W. & Vogelstein, B. Role of BAX in the apoptotic response to anticancer agents. Science 290, 989-992 (2000).
32. Um, H. D. Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species. Oncotarget 7, 5193-5203 (2016).
33. Wang, B. et al. MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A. American journal of cancer research 5, 2719-2729 (2015).
34. Li, Q. et al. Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition. American journal of cancer research 5, 2022-2034 (2015).
35. Zou, F. et al. Targeted deletion of miR-139-5p activates MAPK, NF-kappaB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. The FEBS journal 283, 1438-1452 (2016).
36. Neufert, C., Becker, C. & Neurath, M. F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2, 1998-2004 (2007).
37. Sinicrope, F. A. et al. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer research 55, 237-241 (1995).